Journal of Neurology · 2020 · 40 citations · 28 references
MedicineNeurologyPsychiatryNeuropsychiatryNeurorehabilitationRehabilitationCognitive Behavioral TherapyDisability EvaluationFunctional Neurological DisorderNeurological RehabilitationNeuropsychiatric DisordersNeuropsychiatric RehabilitationCognitive Behavior TherapyFunctional Neurological Symptom DisorderFunctional Performance MeasurementHealth Status IndicesNeurological DisabilityNeuropsychiatric Outcome AssessmentOutcome MeasuresPatient-reported Functional Status
AIM: We report results from a 5-week MDT treatment programme, with individualised sessions, for a selected group of patients with FNSD, delivered in a neuropsychiatric outpatient setting. Primary aims were to (1) reduce symptoms, (2) improve functional performance and (3) improve health status. METHODS: Treatment involved individual sessions of neuropsychiatry, cognitive behavioural therapy, physiotherapy, occupational-therapy, education and family meetings. Outcome measures collected at the beginning and end of treatment and at 6 months, were patient and clinician reported. Aims were assessed by the following: symptom reduction (PHQ15, PHQ9, GAD7, SPIN, Rosenberg); health and social functioning (HONOS, WSAS); functional performance (COPM); health status (EQ-5D-5L) and patient-rated perception of improvement (CGI). RESULTS: Analyses of 78 patients completing the programme and attending a 6-month review revealed high-baseline levels of disability compared to EQ-5DL population norms and high rates of disability and psychopathology as indicated by the WSAS and mental health indices (PHQ9, GAD7, SPIN, Rosenberg's self-esteem). At baseline, 92.3% met the IAPT caseness threshold for depression and 71% met the IAPT caseness threshold for anxiety. A Friedman ANOVA over the three time points and Dunn-Bonferroni post hoc tests indicated statistically significant improvements from admission to discharge and admission to 6-month follow-up. Sustained improvements were seen in somatic symptoms (PHQ15), depression (PHQ9), anxiety (GAD7), health and social functioning (HONOS), functionality (COPM), health status (EQ-5D-5L) and patient-rated clinical global improvement (CGI). CONCLUSION: An MDT can effectively deliver an outpatient programme for FNSD which can serve as an alternative to costlier inpatient programmes. Early identification and treatment of co-morbidities is advised.
28
A Brief Measure for Assessing Generalized Anxiety Disorder
Robert L. Spitzer, Kurt Kroenke, Janet B. W. Williams et al. · Archives of Internal Medicine · 2006 · 31.5K citations
Nursing, Psychiatry, Psychology +17